TuHURA Biosciences annual operating income
2011
2012
2022
2023
2024
2025
TuHURA Biosciences Operating Income Growth & History (HURA)
TuHURA Biosciences's operating income was −$27.3M for fiscal 2025.
View full TuHURA Biosciences company overviewTuHURA Biosciences annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$27.3M | −$10.1M | — |
| 2024 · Dec 31 | 2024-12-31 | −$17.2M | −$4.0M | — |
| 2023 · Dec 31 | 2023-12-31 | −$13.2M | −$3.5M | — |
| 2022 | 2022-12-31 | −$9.7M | — | — |
| 2012 · Jun 30 | 2012-06-30 | −$18,885 | $14,251 | — |
| 2011 · Jun 30 | 2011-06-30 | −$33,136 | — | — |
TuHURA Biosciences quarterly operating income
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q4.11
Q1.12
Q4.12
Q1.13
Q4.12
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$8.8M | −$2.3M | — |
| Q1 2026 | 2026-03-31 | −$7.5M | −$1.2M | — |
| Q4 2025 | 2025-12-31 | −$4.4M | — | — |
| Q3 2025 | 2025-09-30 | −$6.6M | — | — |
| Q2 2025 | 2025-06-30 | −$6.5M | — | — |
| Q1 2025 · Mar 31 | 2025-03-31 | −$6.3M | — | — |
| Q4 2012 | 2012-12-31 | −$3,250 | $7,666 | — |
| Q1 2013 · Sep 30 | 2012-09-30 | −$4,155 | −$297 | — |
| Q4 2012 · Jun 30 | 2012-06-30 | −$982 | $5,849 | — |
| Q1 2012 · Mar 31 | 2012-03-31 | −$3,129 | $698 | — |
| Q4 2011 · Dec 31 | 2011-12-31 | −$10,916 | $3,652 | — |
| Q1 2012 · Sep 30 | 2011-09-30 | −$3,858 | $4,052 | — |
| Q4 2011 · Jun 30 | 2011-06-30 | −$6,831 | — | — |
| Q3 2011 | 2011-03-31 | −$3,827 | — | — |
| Q2 2011 | 2010-12-31 | −$14,568 | — | — |
| Q1 2011 | 2010-09-30 | −$7,910 | — | — |
TuHURA Biosciences operating income trends
Between the periods ended 2011-06-30 and 2025-12-31, TuHURA Biosciences's operating income decreased from −$33,136 to −$27.3M, a change of −$27.3M. The latest reported quarter, Q2 2026, shows −$8.8M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TuHURA Biosciences source filings ↗